Elderly organ transplant recipients have remained underrepresented in clinical trials, despite representing a rapidly growing population. Here, we assessed ageâ€specific effects of CTLA4â€Ig, a fusion protein blocking costimulatory signaling between APCs and T cells through CD28.
|